thrombocytopenic

On top of the asthma and allergies, I'd contracted a blood disorder called idiopathic thrombocytopenic purpura.

Archive 2010-07-01 Lou Anders 2010

The serious problems included a blood disorder (hemolytic uremic syndrome/thrombotic thrombocytopenic purpura) that causes blood clots and can lead to kidney impairment.

New FDA warnings for quinine, commonly used drug for leg cramps 2010

Two recent drug approvals, Vectibix for colon cancer and NPlate for a rare auto-immune condition known as immune thrombocytopenic purpura, are unlikely to become blockbusters soon.

Amgen Bets on Osteoporosis Drug to Revive Its Flagging Growth 2010

The serious problems included a blood disorder hemolytic uremic syndrome/thrombotic thrombocytopenic purpura that causes blood clots and can lead to kidney impairment.

New FDA warnings for quinine, commonly used drug for leg cramps 2010

The vaccine was likely to be associated with benign thrombocytopenic purpura, parotitis, joint and limb complaints, febrile convulsions within two weeks of vaccination and aseptic meningitis (mumps) (Urabe strain-containing MMR).

On Thursday, the Legg report will be published along with... 2009

In documents posted to the FDA's Web site Wednesday, the agency said GlaxoSmithKline's study of the proposed drug "does not provide robust evidence" to support proposed labeling claims that it decreases the frequency and severity of bleeding in people with chronic idiopathic thrombocytopenic purpura.

Proposed Glaxo Antibleeding Drug 2008

The agency staff said GlaxoSmithKline's study of the proposed drug "does not provide robust evidence" to support proposed labeling claims that it decreases the frequency and severity of bleeding in people with chronic idiopathic thrombocytopenic purpura.

FDA Panel Backs Glaxo Platelet Drug Promacta 2008

In a 16-0 vote, the FDA's oncologic drugs advisory committee concluded clinical studies of Glaxo's Promacta demonstrated a favorable risk-benefit profile for its use in short-term treatment of people with chronic immune thrombocytopenic purpura, or ITP, which involves low platelet counts and spontaneous bleeding.

FDA Panel Backs Glaxo Platelet Drug Promacta 2008

The drug would be sold under the proposed brand name Nplate to treat immune thrombocytopenic purpura, or ITP, an autoimmune bleeding disorder marked by below-normal levels of platelets.

Platelet Treatment Wins 2008

The U.S. Food and Drug Administration said Promacta, a treatment Ligand is developing for patients affected by chronic thrombocytopenic purpura, or ITP, in partnership with GlaxoS.ithKline, was unable to significantly reduce bleeding when compared with a placebo.

Matrix Service and New Market Climb; 2008